Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases

BACKGROUND: The survival outcomes of neoadjuvant chemotherapy (NACT) versus adjuvant chemotherapy (ACT) for patients with triple-negative breast cancer (TNBC) remain unclear. Therefore, in this study, a meta-analysis was conducted to analyze current evidence on the survival outcomes of NACT versus A...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Lin-Yu, Hu, Qing-Lin, Zhang, Jing, Xu, Wei-Yun, Li, Xiao-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296918/
https://www.ncbi.nlm.nih.gov/pubmed/32539858
http://dx.doi.org/10.1186/s12957-020-01907-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296918/
https://www.ncbi.nlm.nih.gov/pubmed/32539858
http://dx.doi.org/10.1186/s12957-020-01907-7

Ejemplares similares